Your browser doesn't support javascript.
loading
Therapeutic effect of CT-P59 against SARS-CoV-2 South African variant.
Ryu, Dong-Kyun; Song, Rina; Kim, Minsoo; Kim, Young-Il; Kim, Cheolmin; Kim, Jong-In; Kwon, Ki-Sung; Tijsma, Aloys Sl; Nuijten, Patricia M; van Baalen, Carel A; Hermanus, Tandile; Kgagudi, Prudence; Moyo-Gwete, Thandeka; Moore, Penny L; Choi, Young Ki; Lee, Soo-Young.
Afiliação
  • Ryu DK; Biotechnology Research Institute, Celltrion Inc., Incheon, Republic of Korea.
  • Song R; Biotechnology Research Institute, Celltrion Inc., Incheon, Republic of Korea.
  • Kim M; Biotechnology Research Institute, Celltrion Inc., Incheon, Republic of Korea.
  • Kim YI; College of Medicine and Medical Research Institute, Chungbuk National University, Cheongju, Republic of Korea.
  • Kim C; Biotechnology Research Institute, Celltrion Inc., Incheon, Republic of Korea.
  • Kim JI; Biotechnology Research Institute, Celltrion Inc., Incheon, Republic of Korea.
  • Kwon KS; Biotechnology Research Institute, Celltrion Inc., Incheon, Republic of Korea.
  • Tijsma AS; Viroclinics Biosciences, Rotterdam, the Netherlands.
  • Nuijten PM; Viroclinics Biosciences, Rotterdam, the Netherlands.
  • van Baalen CA; Viroclinics Biosciences, Rotterdam, the Netherlands.
  • Hermanus T; National Institute for Communicable Disease, Johannesburg of the National Health Laboratory Services, South Africa.
  • Kgagudi P; National Institute for Communicable Disease, Johannesburg of the National Health Laboratory Services, South Africa.
  • Moyo-Gwete T; National Institute for Communicable Disease, Johannesburg of the National Health Laboratory Services, South Africa.
  • Moore PL; National Institute for Communicable Disease, Johannesburg of the National Health Laboratory Services, South Africa.
  • Choi YK; College of Medicine and Medical Research Institute, Chungbuk National University, Cheongju, Republic of Korea.
  • Lee SY; Biotechnology Research Institute, Celltrion Inc., Incheon, Republic of Korea. Electronic address: sooyoung.lee@celltrion.com.
Biochem Biophys Res Commun ; 566: 135-140, 2021 08 20.
Article em En | MEDLINE | ID: mdl-34119826
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Imunoglobulina G / Anticorpos Neutralizantes / Anticorpos Monoclonais Humanizados / SARS-CoV-2 / COVID-19 / Anticorpos Antivirais Limite: Animals / Female / Humans País/Região como assunto: Africa Idioma: En Revista: Biochem Biophys Res Commun Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Imunoglobulina G / Anticorpos Neutralizantes / Anticorpos Monoclonais Humanizados / SARS-CoV-2 / COVID-19 / Anticorpos Antivirais Limite: Animals / Female / Humans País/Região como assunto: Africa Idioma: En Revista: Biochem Biophys Res Commun Ano de publicação: 2021 Tipo de documento: Article